A piece of big news for the Basic Attention Token holders as the digital currency exchange Gemini has announced to add support for the native token of Brave Browser. The listing of BAT Token is expected to occur later this month.
Free to use
|Try Bitcoin ProfitBitcoin Profit Review|
Gemini announced this thrilling news in a blog post released on Monday, April 6. According to the blog post, Gemini will allow users to deposit BAT tokens into their Gemini accounts on Friday, April 24, at 9:30 am ET. The trading of BAT will commence afterward but very soon.
Regarding BAT token, Gemini says in the blog post:
“Basic Attention Token is the native currency token of the Brave Browser, which is built to provide a more efficient and effective mechanism for connecting and rewarding users, advertisers, and publishers.”
BAT deposits and trading pairs
Gemini explains how BAT token holders can deposit their coins into their accounts. BAT deposits can only be made with New Gemini Ethereum addresses. As per the announcement, the existing ETH addresses are not supported on the Gemini platform. Therefore, in order to make a deposit, users will need to create new addresses.
Moreover, three trading pairs USD, BTC, and ETH will be available for BAT on the platform as Gemini says, “We will be offering USD, BTC, and ETH trading pairs for BAT on both our continuous order book and our automated block trading system.”
BAT is the Sixth Crypto asset listed on the Gemini platform
Last time, the crypto exchange Gemini listed Bitcoin Cash (BCH) on its platform in Dec 2018 and since then it is the first time that Gemini has added support for any digital asset. Brave Browser’s Basic Attention Token is the sixth digital asset listed on the Gemini platform. Before BAT, Gemini supports Bitcoin, Ether, Bitcoin Cash, Litecoin, and Zcash.
Gemini always looks ahead to support various products and a wide range of new services in order to enhance the cryptocurrency ecosystem. Recently, in the previous month, it included one million new users on its platform during the COVID-19 pandemic.